Literature DB >> 27618277

Relative Bradycardia in Patients With Septic Shock Requiring Vasopressor Therapy.

Sarah J Beesley1, Emily L Wilson, Michael J Lanspa, Colin K Grissom, Sajid Shahul, Daniel Talmor, Samuel M Brown.   

Abstract

OBJECTIVES: Tachycardia is common in septic shock, but many patients with septic shock are relatively bradycardic. The prevalence, determinants, and implications of relative bradycardia (heart rate, < 80 beats/min) in septic shock are unknown. To determine mortality associated with patients who are relatively bradycardic while in septic shock.
DESIGN: Retrospective study of patients admitted for septic shock to study ICUs during 2005-2013.
SETTING: One large academic referral hospital and two community hospitals. PATIENTS: Adult patients with septic shock requiring vasopressors. INTERVENTION: None. MEASUREMENTS: Primary outcome was 28-day mortality. We used multivariate logistic regression to evaluate the association between relative bradycardia and mortality, controlling for confounding with inverse probability treatment weighting using a propensity score.
RESULTS: We identified 1,554 patients with septic shock, of whom 686 (44%) met criteria for relative bradycardia at some time. Twenty-eight-day mortality in this group was 21% compared to 34% in the never-bradycardic group (p < 0.001). Relatively bradycardic patients were older (65 vs 60 yr; p < 0.001) and had slightly lower illness severity (Sequential Organ Failure Assessment, 10 vs 11; p = 0.004; and Acute Physiology and Chronic Health Evaluation II, 27 vs 28; p = 0.008). After inverse probability treatment weighting, covariates were balanced, and the association between relative bradycardia and survival persisted (p < 0.001).
CONCLUSIONS: Relative bradycardia in patients with septic shock is associated with lower mortality, even after adjustment for confounding. Our data support expanded investigation into whether inducing relative bradycardia will benefit patients with septic shock.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27618277      PMCID: PMC5512273          DOI: 10.1097/CCM.0000000000002065

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  42 in total

1.  Previous prescription of β-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis.

Authors:  Alejandro Macchia; Marilena Romero; Pablo Dino Comignani; Javier Mariani; Antonio D'Ettorre; Nadia Prini; Mariano Santopinto; Gianni Tognoni
Journal:  Crit Care Med       Date:  2012-10       Impact factor: 7.598

Review 2.  The heart in sepsis: from basic mechanisms to clinical management.

Authors:  Alain Rudiger; Mervyn Singer
Journal:  Curr Vasc Pharmacol       Date:  2013-03-01       Impact factor: 2.719

3.  Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock.

Authors:  Martin Balik; Jan Rulisek; Pavel Leden; Michal Zakharchenko; Michal Otahal; Hana Bartakova; Josef Korinek
Journal:  Wien Klin Wochenschr       Date:  2012-07-20       Impact factor: 1.704

Review 4.  Pathogenetic mechanisms of septic shock.

Authors:  J E Parrillo
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

5.  Broken barriers: a new take on sepsis pathogenesis.

Authors:  Neil M Goldenberg; Benjamin E Steinberg; Arthur S Slutsky; Warren L Lee
Journal:  Sci Transl Med       Date:  2011-06-22       Impact factor: 17.956

Review 6.  Septic shock.

Authors:  Djillali Annane; Eric Bellissant; Jean-Marc Cavaillon
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

7.  The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM.

Authors:  R Moreno; J L Vincent; R Matos; A Mendonça; F Cantraine; L Thijs; J Takala; C Sprung; M Antonelli; H Bruining; S Willatts
Journal:  Intensive Care Med       Date:  1999-07       Impact factor: 17.440

8.  Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis.

Authors:  M M Parker; J H Shelhamer; C Natanson; D W Alling; J E Parrillo
Journal:  Crit Care Med       Date:  1987-10       Impact factor: 7.598

9.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

10.  Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.

Authors:  Viktor Y Dombrovskiy; Andrew A Martin; Jagadeeshan Sunderram; Harold L Paz
Journal:  Crit Care Med       Date:  2007-05       Impact factor: 7.598

View more
  9 in total

1.  Evaluating Flexible Modeling of Continuous Covariates in Inverse-Weighted Estimators.

Authors:  Ryan P Kyle; Erica E M Moodie; Marina B Klein; Michał Abrahamowicz
Journal:  Am J Epidemiol       Date:  2019-06-01       Impact factor: 4.897

2.  Age-dependent cardiac function during experimental sepsis: effect of pharmacological activation of AMP-activated protein kinase by AICAR.

Authors:  Yu Inata; Giovanna Piraino; Paul W Hake; Michael O'Connor; Patrick Lahni; Vivian Wolfe; Christine Schulte; Victoria Moore; Jeanne M James; Basilia Zingarelli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-06       Impact factor: 4.733

3.  Esmolol inhibits inflammation and apoptosis in the intestinal tissue via the overexpression of NF-κB-p65 in the early stage sepsis rats.

Authors:  Chang-An Guo; Li Ma; Xiao-Lu Su; Ying-Zhen Wang; Ling-Ling Zhen; Bei Zhang; Hong An; Hong-Bin Liu
Journal:  Turk J Gastroenterol       Date:  2020-04       Impact factor: 1.852

4.  Associations among left ventricular systolic function, tachycardia, and cardiac preload in septic patients.

Authors:  Michael J Lanspa; Sajid Shahul; Andrew Hersh; Emily L Wilson; Troy D Olsen; Eliotte L Hirshberg; Colin K Grissom; Samuel M Brown
Journal:  Ann Intensive Care       Date:  2017-02-17       Impact factor: 6.925

5.  Esmolol infusion in patients with septic shock and tachycardia: a prospective, single-arm, feasibility study.

Authors:  Samuel M Brown; Sarah J Beesley; Michael J Lanspa; Colin K Grissom; Emily L Wilson; Samir M Parikh; Todd Sarge; Daniel Talmor; Valerie Banner-Goodspeed; Victor Novack; B Taylor Thompson; Sajid Shahul
Journal:  Pilot Feasibility Stud       Date:  2018-08-03

6.  Abomasitis in calves: A retrospective cohort study of 23 cases (2006-2016).

Authors:  Eloi Guarnieri; Gilles Fecteau; Julie Berman; André Desrochers; Marie Babkine; Sylvain Nichols; David Francoz
Journal:  J Vet Intern Med       Date:  2020-02-14       Impact factor: 3.333

7.  Study into the reversal of septic shock with landiolol (beta blockade): STRESS-L Study protocol for a randomised trial.

Authors:  Ranjit Lall; Dipesh Mistry; Emma Skilton; Nafisa Boota; Scott Regan; Julian Bion; Simon Gates; Anthony C Gordon; Janet Lord; Daniel Francis McAuley; Gavin Perkins; Mervyn Singer; Duncan Young; Tony Whitehouse
Journal:  BMJ Open       Date:  2021-02-16       Impact factor: 2.692

8.  Clinical outcomes in acute pancreatitis with relative bradycardia at fever onset.

Authors:  Takeshi Okamoto; Makoto Arashiyama; Kenji Nakamura; Ryosuke Tsugitomi; Katsuyuki Fukuda
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

9.  Beta-blocker treatment in the critically ill: a systematic review and meta-analysis.

Authors:  Maria Heliste; Ville Pettilä; David Berger; Stephan M Jakob; Erika Wilkman
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.